Target type: biologicalprocess
The series of events in which a lipopolysaccharide stimulus is received by a cell and converted into a molecular signal. Lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:add, PMID:15998797]
Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, is recognized by the innate immune system through a complex cascade of events. This detection process involves specialized immune cells and signaling pathways that ultimately lead to the activation of inflammatory responses.
The initial step in LPS recognition involves the interaction of LPS with specific pattern recognition receptors (PRRs). The most critical PRR for LPS recognition is Toll-like receptor 4 (TLR4), a transmembrane protein expressed on the surface of various immune cells, including macrophages, dendritic cells, and neutrophils. TLR4 forms a complex with accessory proteins, such as MD-2 and CD14, which facilitate its binding to LPS.
Upon binding to TLR4, LPS triggers a series of intracellular signaling events. This process begins with the activation of adaptor proteins, such as MyD88 and TRIF, which are recruited to the TLR4 complex. These adaptor proteins activate downstream signaling pathways, including the NF-κB pathway and the MAPK pathway.
The NF-κB pathway is a key regulator of inflammatory gene expression. Activation of NF-κB leads to the production of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6. These cytokines mediate a wide range of inflammatory responses, including fever, pain, and tissue damage.
The MAPK pathway also plays a crucial role in LPS-induced inflammation. Activation of MAPK signaling cascades leads to the production of chemokines, which attract immune cells to the site of infection.
In addition to the activation of inflammatory responses, LPS detection also triggers the production of type I interferons (IFNs). IFNs are antiviral cytokines that help to control viral infections.
The detection of LPS by the immune system is essential for the host's defense against Gram-negative bacterial infections. However, excessive or uncontrolled LPS signaling can lead to septic shock, a life-threatening condition characterized by systemic inflammation and organ dysfunction.
In summary, the detection of LPS involves a complex interplay between PRRs, adaptor proteins, signaling pathways, and immune cells. This process is essential for the host's defense against Gram-negative bacteria but can also contribute to the development of septic shock.'
"
Protein | Definition | Taxonomy |
---|---|---|
Lymphocyte antigen 96 | A lymphocyte antigen 96 that is encoded in the genome of human. [TLR:AMM, UniProtKB:Q9Y6Y9] | Homo sapiens (human) |
Scavenger receptor class B member 1 | A scavenger receptor class B member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WTV0] | Homo sapiens (human) |
Nuclear receptor subfamily 4 group A member 1 | A nuclear receptor subfamily 4 immunity group A member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P22736] | Homo sapiens (human) |
Toll-like receptor 4 | A Toll-like receptor 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:O00206] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
carvedilol | carbazoles; secondary alcohol; secondary amino compound | alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent | |
rimcazole | rimcazole: RN given refers to (cis)-isomer; structure given in first source | carbazoles | |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
methotrexate | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent | |
celastrol methyl ester | celastrol methyl ester: isolated from Tripterygium wilfordii; potent inhibitory activity on both Kir2.1 and ERG1 potassium channels, leading to LONG QT SYNDROME | carboxylic ester | |
alitretinoin | Alitretinoin: A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA. | retinoic acid | antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist |
xanthohumol | xanthohumol : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2' and 4', a methoxy group at position 6' and a prenyl group at position 3'. Isolated from Humulus lupulus, it induces apoptosis in human malignant glioblastoma cells. xanthohumol: from hop plant, Humulus lupulus | aromatic ether; chalcones; polyphenol | anti-HIV-1 agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor; metabolite |
curcumin | curcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
parthenolide | sesquiterpene lactone | drug allergen; inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug | |
triptohypol C | triptohypol C : A pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. | benzenediols; monocarboxylic acid; pentacyclic triterpenoid | apoptosis inducer; plant metabolite |
cytosporone b | cytosporone B: a Nur77 agonist; structure in first source | aromatic ketone | |
resatorvid | |||
crx-526 | CRX-526: aminoalkyl-glucosaminide-phosphate; lipid A-mimetic with anti-inflammatory properties; structure in first source |